NCT00936585View on ClinicalTrials.gov

NIH Substudy of AIN457 (Anti-IL-17 Monoclonal Antibody) for Treatment of Moderate to Severe Crohn's Disease

NATerminatedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

February 28, 2011

Study Completion Date

February 28, 2011

Conditions
ColitisCrohn's DiseaseInflammatory Bowel Disease
Interventions
OTHER

Immunologic Monitoring

blood draws and colonoscopy before and after receiving study drug

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

Sponsors

Collaborators (1)

Novartis
All Listed Sponsors
collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

collaborator

Novartis

INDUSTRY

lead

National Institutes of Health Clinical Center (CC)

NIH